Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-09-11
2010-02-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S561000, C514S645000
Reexamination Certificate
active
07662854
ABSTRACT:
The invention provides a compound of one of the formulae (A), (B), (C), (D), (E), (F) as herein defined, or a salt thereof, for use in the treatment of a condition associated with increased or decreased HIF levels or activity, or a condition in which an increase or decrease in HIF levels or activity may be beneficial.
REFERENCES:
patent: 4273779 (1981-06-01), Finch
patent: 4446038 (1984-05-01), Schlicht et al.
patent: 4623733 (1986-11-01), Higashide et al.
patent: 4752602 (1988-06-01), Lipsky et al.
patent: 4797471 (1989-01-01), Teetz et al.
patent: 5206343 (1993-04-01), Henke et al.
patent: 5439930 (1995-08-01), Seredenin et al.
patent: 6200974 (2001-03-01), Edwards et al.
patent: 1 620 359 (1969-12-01), None
patent: 44 10 453 (1995-09-01), None
patent: 0 148 752 (1985-07-01), None
patent: 0 178 665 (1986-04-01), None
patent: 0 293 029 (1988-11-01), None
patent: 0 185 225 (1990-01-01), None
patent: 6.969 (1969-06-01), None
patent: 2 662 359 (1991-11-01), None
patent: 1226394 (1971-03-01), None
patent: 61218522 (1986-09-01), None
patent: 61249993 (1986-11-01), None
patent: 7138167 (1995-05-01), None
patent: 2001588 (1993-10-01), None
patent: 2079307 (1997-05-01), None
patent: 2 111 746 (1998-05-01), None
patent: 2 141 943 (1999-11-01), None
patent: WO 97/24145 (1997-07-01), None
patent: WO 99/07729 (1999-02-01), None
patent: WO 00/71514 (2000-11-01), None
patent: WO 00/74725 (2000-12-01), None
patent: WO 01/93841 (2001-12-01), None
patent: WO 02/074981 (2002-09-01), None
Cited ref-STN-11518157M.
Communication from European Patent Office issued in Application No. 03712396.5-1521, dated May 22, 2007 (5 pages).
Isao; “Oligopeptide;” Patent Abstracts of Japan; Publication No. 58099453, publication date Jun. 13, 1983.
Thouin et al.; “Effective Synthesis of Enantiopure Hydroxamates by Displacement of Resin-Bound Esters with Hydroxylamine;” Tetrahedron Letters 41; pp. 457-460; 2000.
Walter et al.; “Hydroxamate Inhibitors of Aeromonas Hydrophila AE036 Metallo-β-Lactamase;” Bioorganic Chemistry; vol. 27; pp. 35-40; 1999.
Clifton et al.; “Structure of Proline 3-hydroxylase. Evolution of the Family of 2-oxoglutarate Dependent Oxygenases;” Eur. J. Biochem.; vol. 268; pp. 6625-6636; 2001.
Walter et al.; “Synthesis of Metallo-β-Lactamase Inhibitors;” Tetrahedron; vol. 53, No. 21; pp. 7275-7290; 1997.
Jaakkola et al.; Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation; Science; vol. 292; Apr. 20, 2001.
Blodgett et al.; “Specific Cleavage of Peptides Containing an Aspartic Acid (β-Hydroxamic Acid) Residue;” Journal of the American Chemical Society; vol. 107, No. 14, pp. 4305-4313; 1985.
Bender et al.; “Sigmoid and Bell-Shaped pH-Rate Profiles in α-Chymotryspin-Catalyzed Hydrolyses. A Mechanistic Correlation;” Journal of the American Chemical Society; vol. 85; pp. 358-359; 1963.
Zukowski et al.; “Modification of 6-Aminopenicillanic Acid Derivatives;” Chemical Abstracts, ol. 86; No. 11; p. 603; 1977.
Database Crossfire Beilstein XP002244406; Registration No. 5623186; 1993.
Database Crossfire Beilstein XP002244407; Registration No. 2900977; 1998.
Database Crossfire Beilstein XP002244408; Registration No. 4152395; 1995.
Kwon et al.; “Photooxygenation of Ascorbic Acid Derivatives and Model Compounds;” Journal of the American Chemical Society; vol. 111, No. 5, pp. 1854-1860; 1989.
Wehbie et al.; “Rat Liver γ-Butyrobetaine Hydroxylase Catalyzed Reaction: Influence of Potassium, Substrates, and Substrate Analogues on Hydroxylation and Decarboxylation;” Biochemistry; vol. 27; pp. 2222-2228; 1988.
Balsiger et al.; “Synthesis of Potential Anticancer Agents. XVIII. Analogs of Carbamoyl Phosphate;” Chemical Abstracts; vol. 54, No. 11; p. 10855; 1960.
Takayama et al.; “Selective Inhibition of β-1,4- and α-1,3-Galactosyltransferases: Donor Sugar-Nucleotide Based Approach;” Bioorganic & Medicinal Chemistry; vol. 7; pp. 401-409; 1999.
Cunliffe et al.; “Novel Inhibitors of Prolyl 4-Hydroxylase. 3. Inhibition by the Substrate Analogue N-Oxaloglycine and Its Derivatives;” Journal of Medicinal Chemistry; vol. 35; pp. 2652-2658; 1992.
Hoffmann et al.; “A Peptide Synthesis via Hydroxamic Acids;” Journal of Organic Chemistry; vol. 29; pp. 748-751; 1964.
Freedman et al.; “Structural Basis for Recruitment of CBP/p300 by Hypoxia-Inducible Factor-1α;” PNAS; vol. 99, No. 8; pp. 5367-5372; Apr. 16, 2002.
Lando et al.; “Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch;” Science; vol. 295; pp. 858-861; Feb. 1, 2002.
Lando et al.; “FIH-1 is an Asparaginyl Hydroxylase Enzyme that Regulates the Transcriptional Activity of Hypoxia-Inducible Factor;” Genes & Development; vol. 16; pp. 1466-1471; 2002.
Lee et al.; “The Structure-Activity Relationships of the Triketone Class of HPPD Herbicides;” Pesticide Science; vol. 54; pp. 377-384; 1998.
U.K. Patent Office Search Report for Application No. GB 0206711.4.
Otani et al., “N-Benzoyl derivatives of amino acids and amino acid analogs as growth inhibitors in microbial antitumor screen,” J. Pharm. Sci., vol. 68, pp. 1366-1369, Nov. 1979.
International Search Report for Application No. PCT/GB03/01239.
The Merck Index, “Tricarballylic Acid”, 12thEdition, Item 9752, (1996), p. 1641.
Patent Abstract of Japan vol. 007, No. 201 (C-184), & JP 58 099453 A, 1983.
Chem-Impex International, Inc. company on-line catalog product listing, 2009.
Zukowski, Edward, et al., “Modification of 6-aminopenicillanic Acid Derivatives”, Chemical Abstracts, vol. 86, No. 11, Mar. 14, 1977, p. 603, Abstract No. 72508v.
Balsiger, Rudolf W., et al., “Synthesis of Potential Anticancer Agents”, Chemical Abstracts, vol. 54, No. 11, Jun. 10, 1960, p. 10855, Abstract No. 10856d.
Maxwell Patrick Henry
Pugh Christopher William
Ratcliffe Peter John
Schofield Christopher Joseph
Chu Yong
Finnegan Henderson Farabow Garrett & Dunner LLP
ISIS Innovation Limited
Saeed Kamal A
LandOfFree
HIF hydroxylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIF hydroxylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIF hydroxylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4194064